It is expected to be administered weekly, starting with a lower dose to minimise side effects (1) Retatrutide has some common side effects (1), similar to Wegovy and Mounjaro, including: Nausea Vomiting Constipation Diarrhoea Since retatrutide can help increase weight loss in an additional way to Wegovy and Mounjaro, these side effects could be more intense (1)
it is not unique to GLP-1 therapy
Ethics declarations Ethics Not applicable
Medicare has historically not covered weight-loss-only indications, though the 2026 GLP-1 Bridge program provides temporary access to Foundayo at $50/month through December
According to the UN, the global population of individuals aged 65 years and above is expected to increase significantly, more than doubling from 761 million in 2021 to 1.6 billion by 2050
Also read: Science-Based Hydration Strategies for Better Living & Performance You Didnt Know (05/05/25) Longevity community couldnt resist GLP1s Given our newsletters core focus is on longevity itself, we couldnt help but give the perspective of the longevity community on GLP-1s and other WLMs
